At the time of writing, Conduit Pharmaceuticals Inc [CDT] stock is trading at $1.16, down -4.92%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CDT shares have lost -1.69% over the last week, with a monthly amount drifted -64.85%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
For the past year, the stock price of Conduit Pharmaceuticals Inc fluctuated between $1.09 and $392.00. Conduit Pharmaceuticals Inc [NASDAQ: CDT] shares were valued at $1.16 at the most recent close of the market.
Analyzing the CDT fundamentals
Gross Profit Margin for this corporation currently stands at 0.54% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.13 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.95.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1045 points at the first support level, and at 1.0490 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.2360, and for the 2nd resistance point, it is at 1.3120.
Ratios To Look Out For
It is important to note that Conduit Pharmaceuticals Inc [NASDAQ:CDT] has a current ratio of 0.12. Further, the Quick Ratio stands at 0.12, while the Cash Ratio is 0.59.
Transactions by insiders
Recent insider trading involved Nirland Ltd, 10% Owner, that happened on Oct 03 ’24 when 1.5 million shares were sold. 10% Owner, Nirland Ltd completed a deal on Oct 04 ’24 to sell 1.37 million shares. Meanwhile, 10% Owner Nirland Ltd sold 0.94 million shares on Oct 07 ’24.
